The clock is ticking down for the 400 workers at a Novartis plant which was put on the block last year as the company cuts costs to finance new therapies.?There is some hope, however, with half a dozen companies taking a look at the U.K. site.?
Sanofi may be on the up-and-up thanks to its vaccines unit and new anti-inflammatory star Dupixent, but the company still intends to shed more than 600 jobs in its home country over the next couple of years.
Teva Pharmaceuticals will lay off 208 people this year at their Pennsylvania-based locations, according to notices filed with the Pennsylvania Department of Labor and Industry.